HUMAN PAPILLOMAVIRUS INFECTION
Clinical trials for HUMAN PAPILLOMAVIRUS INFECTION explained in plain language.
Never miss a new study
Get alerted when new HUMAN PAPILLOMAVIRUS INFECTION trials appear
Sign up with your email to follow new studies for HUMAN PAPILLOMAVIRUS INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New HPV vaccine trial aims to protect kids and teens from cancer
⭐️ VACCINE ⭐️ Recruiting nowThis study tests a bivalent HPV vaccine in healthy infants (9 months), toddlers (15 months), children (2-5 years), and unmarried young women (15-20 years) in Ghana. Researchers want to see if the vaccine is safe and triggers a strong immune response, especially when given alongsi…
Matched conditions: HUMAN PAPILLOMAVIRUS INFECTION
Phase: PHASE2 • Sponsor: International Vaccine Institute • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:34 UTC
-
New heat treatment and AI could revolutionize cervical cancer prevention
Disease control Recruiting nowThis study in El Salvador tests a new thermal ablation device (IRIS™) to treat cervical precancer and an AI algorithm to help decide who needs treatment. About 5,000 HPV-positive women aged 30-49 will receive the treatment and be followed for one year to see if the precancer is c…
Matched conditions: HUMAN PAPILLOMAVIRUS INFECTION
Phase: NA • Sponsor: Basic Health International, Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Could a simple Self-Swap replace the speculum for cervical cancer screening?
Diagnosis Recruiting nowThis study is testing whether self-collected vaginal samples for HPV testing work as well as samples collected by a doctor during a pelvic exam. The goal is to make cervical cancer screening more accessible and comfortable. About 500 people referred for colposcopy or cervical pro…
Matched conditions: HUMAN PAPILLOMAVIRUS INFECTION
Phase: NA • Sponsor: National Cancer Institute (NCI) • Aim: Diagnosis
Last updated Jun 27, 2026 14:00 UTC
-
New Same-Day test could transform cervical cancer screening in Low-Resource areas
Diagnosis Recruiting nowThis study evaluates a same-day cervical cancer screening approach for women in Cameroon. Participants first collect their own sample for HPV testing, and if positive, they receive a digital cytology exam on the same day to determine if further treatment is needed. The goal is to…
Matched conditions: HUMAN PAPILLOMAVIRUS INFECTION
Phase: NA • Sponsor: University Hospital, Geneva • Aim: Diagnosis
Last updated Jun 27, 2026 12:23 UTC
-
Mail-in HPV test could save lives of women skipping pap smears
Diagnosis Recruiting nowThis study is testing whether giving women a simple self-sampling kit to use at home can increase the number of women who get screened for cervical cancer. The trial will enroll 15,000 women in Czech Republic, especially those who haven't had a Pap smear in over 3 years. Particip…
Matched conditions: HUMAN PAPILLOMAVIRUS INFECTION
Phase: NA • Sponsor: The Institute of Molecular and Translational Medicine, Czech Republic • Aim: Diagnosis
Last updated Jun 27, 2026 12:00 UTC
-
New study aims to get more latino teens the HPV vaccine
Prevention Recruiting nowThis study tests whether training and supporting healthcare providers can increase HPV vaccination rates among Latino adolescents. Researchers will work with nine health centers to implement strategies like provider education and clinical plans. The goal is to see if these effort…
Matched conditions: HUMAN PAPILLOMAVIRUS INFECTION
Phase: NA • Sponsor: The University of Texas Health Science Center, Houston • Aim: Prevention
Last updated Jun 27, 2026 12:28 UTC
-
Liquid biopsy trial aims to outsmart HPV cancers
Knowledge-focused Recruiting nowThis study is testing whether liquid biopsies (blood tests that look for bits of HPV and tumor DNA) can help doctors monitor treatment and spot early signs of cancer returning in people with HPV-related cervical and oropharyngeal cancers. Researchers will follow 480 participants …
Matched conditions: HUMAN PAPILLOMAVIRUS INFECTION
Sponsor: The Institute of Molecular and Translational Medicine, Czech Republic • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC